Phibro Animal Health | PAHC - Current Liabilities


Phibro Animal Health reported $295.79M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Align Technology USD 1.91B 4.9M Sep/2026
ANI Pharmaceuticals USD 328.72M 45.06M Sep/2026
Aurora Cannabis CAD 73.43M 6.5M Jun/2026
Bristol-Myers Squibb USD 18.75B 94M Sep/2026
Canopy Growth CAD 166.75M 8.31M Jun/2026
Corcept Therapeutics USD 177.68M 23.87M Sep/2026
Eli Lilly USD 47B 745M Sep/2026
Henry Schein USD 3.6B 110M Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Merck USD 28.8B 1.07B Sep/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Pacira USD 126.1M 4.08M Sep/2026
Phibro Animal Health USD 295.79M 20.68M Sep/2026
Prestige Brands USD 168.5M 14.7M Sep/2026
Supernus Pharmaceuticals USD 285.4M 61.98M Sep/2026
Zoetis USD 2.68B 621M Sep/2026